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It is well-known that gender is an independent risk factor for some types of cardiac
arrhythmias. For example, males have a greater prevalence of atrial fibrillation and
the Brugada Syndrome. In contrast, females are at increased risk for the Long QT
Syndrome. However, the underlying mechanisms of these gender differences have not
been fully identified. Recently, there has been accumulating evidence indicating that
sex hormones may have a significant impact on the cardiac rhythm. In this review, we
describe in-depth the molecular interactions between sex hormones and the cardiac
ion channels, as well as the clinical implications of these interactions on the cardiac
conduction system, in order to understand the link between these hormones and the
susceptibility to arrhythmias.
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INTRODUCTION
Cardiac arrhythmias encompass a wide spectrum of clinical presentations, ranging from benign
extrasystoles on electrocardiogram (ECG) to arrhythmias that may pose a significant clinical threat,
such as atrial fibrillation (AF), which is an important cause of stroke, and ventricular tachycardia
or fibrillation (VT/VF) that can result in sudden cardiac death (SCD) (1). A significant proportion
of SCD events occurs in patients without any known cardiac disease, and even in the presence of
diagnosis of a cardiac disorder, current knowledge on prediction of arrhythmic risk is limited (2).
It is well-known that gender is an independent risk factor for some types of cardiac arrhythmias.
For example, males have a greater prevalence of AF and the Brugada Syndrome (3, 4). In contrast,
females are at increased risk for Torsade de pointes (TdP), both in congenital and acquired Long
QT Syndrome (LQTS) (5). Despite the fact that the incidence of a variety of cardiac arrhythmias
differs between men and women, the underlying mechanisms of these gender differences have not
been clearly identified.
The predominant factors determining gender differences are the sex hormones. These steroid
hormones are known to exert their multiple physiological effects by binding to cytosolic or
membrane receptors (6). One of the target organs of action of these hormones is the heart, and
there is now accumulating evidence indicating that sex hormones may have a significant impact
on the cardiac rhythm (7, 8). It was initially thought that sex hormones only had genomic actions,
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such as exerting their effects through the regulation of
transcriptional processes, hence influencing gene expression after
nuclear translocation (9). However, recent literature has shown
that their scope of action goes well-beyond that, and encompasses
non-genomic actions, as well. In fact, these hormones can acutely
regulate cardiac ion channels and affect their currents, and these
actions are mediated by transcriptional processes, such as RNA
and protein synthesis (6–8).
In this review, we aim to describe in-depth the molecular
interactions between sex hormones and the cardiac ion channels,
as well as the clinical implications of these interactions on the
cardiac conduction system, in order to understand the link
between these hormones and the susceptibility to arrhythmias.
TYPES AND FUNCTIONS OF SEX
HORMONES
Sex hormones play a key role in reproduction and sexual
development. Moreover, they are also involved in other
processes, such as regulating cholesterol levels and determining
inflammatory response. They are produced by the gonads
(ovaries and testicles) and adrenal glands. Estrogen and
progesterone are the two main female sex hormones. Estrogen
promotes growth of uterine tissue and breasts, maintains
libido and secondary sexual characteristics in females, whereas
progesterone has a significant role in the female menstruation
cycle and pregnancy. Themainmale sex hormone is testosterone,
but females also produce a small amount of this hormone.
Testosterone affects many organs and has a variety of functions,
including spermatogenesis, muscle growth, maturation of
genitalia and bone metabolism (Figure 1).
Fluctuations in Sex Hormone Levels
The levels of sex hormones change during life as part of
physiological processes. For example, the female sex hormones
increase during adolescence and drop during menopause.
Moreover, cyclic hormonal changes occur during the
reproductive cycle. In certain situations, fluctuations of sex
hormone levels can lead to health issues such as infertility,
change in sexual desire, hair loss, osteoporosis, etc.
Sex hormone fluctuations also occur in the short-term.
For example, there is a substantial circadian variation in the
circulating levels of testosterone. Normal values for testosterone
in a healthy adult male range between 300 and 1,000 ng/dL
(10). The highest level of testosterone is reached in the morning,
and therefore, it is recommended to determine it between 8:00
and 10:00 am in order to achieve accurate (and comparable)
measurements (11). In addition, there may also be a seasonal
variability of testosterone measurements. However, this is a
contradictive issue, since there is both literature supporting and
rejecting this hypothesis (12). After the third decade of life,
men start to have ∼1–2% decrease of testosterone per year (13).
Finally, the amount of active serum testosterone is heavily reliant
on the concentrations of sex hormone-binding globulin (SHBG)
and albumin, thus being subject to fluctuations in those proteins.
Such changes of testosterone levels across the healthy population
pose challenges in determining its effect on cardiac physiology, as
values measured have to be adjusted for multiple factors, in order
to have an unbiased result.
Estradiol (E2), the most potent estrogen, has the function
of regulating reproductive cycles in females (Table 1, Figure 2).
Evaluating estradiol levels is challenging, given that it changes
widely during the menstrual cycle. Estradiol increases prior to
ovulation and falls during ovulation, and there is a gradual
increase of estradiol and then decrease prior to its lowest point
in early menses. Moreover, it is also subject to a circadian
variability, which is further affected by the menstrual cycle in
post-menopausal women, estrogen levels decrease and show
fluctuations (14).
Sex Hormones and Exercise
Both testosterone and estrogen play an important role in the
neuromuscular adaptation to exercise in males and females. This
adaptation is mediated by the hypothalamic-pituitary-gonadal
(HPG) axis, which is responsible for both acute and chronic
responses to exercise (15). In males, testosterone is pivotal for
athletic activity during adolescence and in adulthood. While it is
well-known that exercise acutely increases testosterone levels in
men, its impact in the long-term is much less clear (16). Multiple
cross-sectional studies have identified decreased testosterone
levels in endurance and resistance athletes, as compared to
controls. Furthermore, a study by Grandys et al. (17) found
that testosterone levels vary significantly even within the athlete
group, depending on the training period. In fact, testosterone
increases during low-intensity training periods in comparison to
high-intensity training periods. Conversely, in a cross-sectional
study by Fitzgerald et al. (18) which compared trained cyclists to
recreational cyclists, the former group had higher levels of serum
testosterone than the latter. The conflicting results could be due
to the retrospective nature of the studies evaluating the impact of
chronic exercise. On the other hand, the few prospective studies
also showed contradictory results, most likely due to differences
in the training period, the magnitude of training stimulus and the
volume of training load employed. In females, the acute effects
of exercise training on the HPG axis are less well-known. Nindl
et al. (19) have shown that estradiol may increase acutely after
exercise, whereas the long-term effects of exercise still need to
be determined.
THE INTERACTION BETWEEN SEX
HORMONES AND CARDIAC ION
CHANNELS
The differences in cardiac electrical activity between males and
females had been observed with the earliest ECG recordings a
century ago. In the meantime, while the scientific community has
gathered a thorough understanding of the ECG as the net sum
of electrical current flow of ions crossing the cardiomyocyte cell
membrane, the molecular basis underlying gender differences are
still largely debated (20).
The transit of ions across the cell membrane is permitted
by specific transmembrane proteins, i.e., ion channels. Any
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FIGURE 1 | The effects of testosterone on the human body.
TABLE 1 | Sex hormones and their biological functions.
Sex hormones Biological functions
Androgens
Testosterone Development of male genitalia, increase in muscle and
bone mass, growth of body hair
Dihydrotestosterone Catalyzed from testosterone, considerably more potent
agonist of the androgen receptor
Androstenedione Precursor of testosterone, endogenous pro-hormone,
weak androgenic, and estrogenic activity
Estrogens
Estrone (E1) Weak estrogen, precursor of estradiol
Estradiol (E2) Potent estrogenic hormone: regulation of the estrous
and menstrual female reproductive cycle, development
of female genitalia, bone growth and density, skin health,
neuroprotective
Estriol (E3) Weak estrogen, almost undetectable in non-pregnant
women, high levels during pregnancy
Estetrol (E4) Weak estrogen found only in pregnancy, physiological
function unknown
change that affects the flow of ions through these channels will
have an impact on the ECG (21). The voltage-gated channels
are the major ion channel group in charge of cardiac electric
activity. These possess a rapid response mechanism to changes in
membrane voltage and interact with each other to produce the
cellular action potential (AP). In the myocardium, the rapidly
activating sodium channel is the principal driver for cellular
depolarization, while L-type calcium current is responsible for
the plateau phase and the delayed rectifier potassium current
is mostly in charge of the repolarization. These give rise to
the clinically measurable QRS complex, the magnitude and
dispersion of which are strongly influenced by changes to the
sodium current, and the QT interval, which is dependent on the
calcium and potassium currents (22). These parameters are also
widely influenced by cell-cell connections, which are mediated by
the connexin family of proteins at gap junctions, and therefore,
ECG abnormalities often occur in diseases of the connexome
(e.g., arrhythmogenic right ventricular cardiomyopathy). A
decrease in cell-cell conductance typically leads to a longer QRS
duration with or without terminal activation delay (23). Since the
above-mentioned gender differences are not present at birth, but
only appear at puberty, this has led to the hypothesis that they are
dependent on sex hormone regulation (24).
Cardiac myocytes have a variety of receptors for sex
hormones, specifically estrogen, progesterone and testosterone,
whose activation can alter the electrical activity of the heart
through modulation of ion channels. Although literature is
scarce, fluctuating hormone levels can lead to changes in
the behavior and expression of myocardial ion channels
(Figure 3) (25).
The Effect of Sex Hormones on Ventricular
Ion Channels
Ventricular Potassium Channels
Potassium channels play a pivotal role in the regulation of muscle
excitability. Potassium conductance through potassium channels
present on the plasma membrane enables the membrane
potential to reach the equilibrium potential of potassium,
leading to hyperpolarization or accelerated repolarization of
action potential in muscle cells. This results in a controlled cell
excitability, elicited by various signals such as depolarization
of membrane potential, ligand-binding, and so on (26). Sex
hormones can regulate these via modulation of gene expression
(by binding to their unique nuclear receptor) or non-genomic
pathways after binding to membrane receptors. The rapid
non-genomic effects of sex hormones are exerted through the
activation of specific signaling pathways, which are initiated
from sex hormone receptors or binding proteins in the plasma
membrane and cytosol. Furthermore, sex hormones may also
directly bind to potassium channels or the auxiliary subunits
to modulate the activities of potassium channel blockers and
potassium channel openers.
Several different types of currents pass through the potassium
channels, i.e., the transient outward current (Ito), the rapid-
delayed rectifier current (Ikr), the slow delayed-rectifier current
(Iks), and the inward rectifier potassium current (Ikl). However,
there are contradicting reports concerning the interaction of sex
hormones and the potassium channels. Previous studies either
showed no influence of sex hormones on Ito (27) or greater
expression in males than in females (28, 29). Consequently,
an increased expression of this current was demonstrated
in ovariectomized mice, with a concurrent increase in their
associated channel mRNA (30). This has been confirmed by the
fact that in the high estradiol state (as is pregnancy), a reduction
of Ito is observed (31).
Similarly to the Ito, the Ikr has also been shown to be either not
influenced by gender (29), or less expressed in females (32). This
was confirmed in an in vitro study upon acute administration
of exogenous estradiol on cultured guinea pig cardiomyocytes
with human ether-a-go-go-related gene (hERG) overexpression,
which unmasked the blockage of the hERG channel and thus
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FIGURE 2 | The synthesis of sex hormones from their precursor cholesterol.
FIGURE 3 | The influence of sex hormones on ventricular ion channels. Testosterone increases repolarizing currents Ikr and Iks and the Ito, while it acutely increases
the L-type calcium current ICaL. Estrogen has a more complex effect. It directly blocks the Ikr, but may also increase it by promoting HERG trafficking. Furthermore, it
reduces the KCNE1, thereby reducing Iks. These alterations result in prolongation of AP duration by estrogens, but its shortening by testosterone.
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Ikr (33). In various animal models, the Iks has been observed as
either larger in males (34), larger in females or with no gender
difference at all (29), depending on which region the cells were
taken from. This is in line with increasing evidence suggesting
that the differences exerted by sex hormones may not be uniform
across the heart. As in the case of Ikr, this current has also been
shown to be blocked upon administration of exogenous estradiol
through blockage of its related channels (KCNQ1/KCNE1) (35).
Interestingly, while this current is enhanced by progesterone, as
shown in the in vitro patch clamping study by Nakamura et al.
(36) the hERG channel trafficking is reduced with progesterone.
Furthermore, it has been demonstrated in guinea pig ventricular
myocytes through acute applications of physiological serum
levels of testosterone that this increases the outward potassium
currents (Ikr and Iks) and the inward rectifier current (Ikl) (7).
Thus, progesterone and testosterone shorten the ventricular APs,
while estrogen lengthens the APs andmay exert a pro-arrhythmic
effect (8).
Ventricular Calcium Channels
The L-type Ca2+ channels are heteromultimeric proteins,
consisting of multiple subunits. Similar to the mechanism with
the above-mentioned potassium channels, signaling of gonadal
steroids has traditionally been associated to a genomic action, i.e.,
the transcriptional control of target genes through binding of the
nuclear receptors and ligands to the genomic consensus sequence
in reproductive organs. However, several biological actions of
gonadal steroids have recently been shown to be too rapid to be
compatible with transcriptional mechanisms.
The evidence on interaction of sex hormones and the cardiac
calcium channels is conflicting. In fact, there are reports of
increased (29), decreased (32), or indifferent calcium currents
(ICa) in females as compared to males (27). Similarly to what
was observed for the cardiac potassium channels, there is
evidence of regional heterogeneity in the different interactions
between sex hormones and ion channels (37). In fact, in
animal studies, gender differences were observed for the ICa in
the apex, but not in the base of the left ventricle of rabbits
(37). Moreover, an increase in L-type calcium channels was
shown in the basal cardiomyocytes of rabbits by incubating
these with physiological concentrations of estrogen. This effect,
however, was not seen in the apical cardiomyocytes (38). Acute
administration of progesterone was shown to decrease the ICa by
60% (8). Interestingly, ovariectomized mice had an increase in
the expression of L-type calcium channels, which were reversed
upon administration of exogenous estrogen (39). Testosterone
also plays a part in the modulation of the voltage-gated calcium
channels. It is a selective and potent inhibitor of L-type calcium
channels of vascular smooth muscles (40). The likely reason
may be the fact that it blocks the major α1 subunit of the L-
type channel, similarly to the effects of the commonly prescribed
calcium channel antagonists.
Ventricular Sodium Channels
The influence of sex hormones on the cardiac sodium channels
are yet unknown. Even though there is no reported association
between sex hormones and the LQT3 (41), there is increasing
evidence linking sex hormones to the phenotypic expression of
the Brugada Syndrome (42), despite the fact that both diseases
stem from cardiac sodium channel mutations. The interesting
link between the Brugada Syndrome and sex hormones is
thoroughly discussed in the later section.
Ventricular Ryanodine Receptor
The contractile function of the heart is determined by
intracellular calcium concentration, which is influenced by
the expression and activity of calcium regulatory proteins.
When the sarcolemma is depolarized, the voltage-gated L-
type calcium channels are opened and the influx of calcium
into cytosol increases. This influx induces a massive release
of calcium from the sarcoplasmic reticulum via the ryanodine
receptor (RyR). This results in a sudden increase in calcium,
which then triggers cardiac contraction. Tsang et al. (43)
demonstrated how testosterone increased contraction and
relaxation velocities that were associated with increased calcium
release and recovery through activities of the RyR receptor
and sarcoendoplasmic reticulum calcium transport ATPase
(SERCA2). This observation may explain the predominantly
male phenotype in catecholaminergic polymorphic ventricular
tachycardia (CPVT).
SEX HORMONES AND VENTRICULAR
ARRHYTHMIAS
Sex hormones may alter the susceptibility to ventricular
tachyarrhythmias in patients with underlying structural heart
disease and in those with cardiac channelopathies.
Coronary Artery Disease
The higher incidence of coronary artery disease, and especially of
SCD, in male patients but also in females following menopause,
has highlighted the role of estrogen as a cardioprotective
hormone. It was shown that estrogen has beneficial effects by
improving cardiac function, preserving calcium homeostasis and
inhibiting the mitochondrial apoptotic pathway (44). In the
context of an ischemic insult to the heart, reperfusion that
accompanies the opening of a blocked coronary artery may
trigger arrhythmias and result in SCD. Estrogen was shown
to decrease reperfusion arrhythmias in multiple animal studies.
Savergnini et al. (45) demonstrated in young female rats that
administration of estradiol was protective against this type of
arrhythmia. This finding was also confirmed by Wang et al. (46)
who showed that this action was mediated by the genomic action
of estrogen, mainly the upregulation of the Estrogen Receptor β
(Erβ) activation.
The role of testosterone during cardiac ischemia and in
the prevention of reperfusion arrhythmias is controversial.
Preclinical studies showed that pretreatment with testosterone
of rat hearts exposed to ischemia decreased arrhythmias, as
effectively as it was the case after estradiol administration
(47). Likewise, testosterone replacement was shown to exert
cardioprotective effects in orchiectomized rats (48). In another
study in isolated rat hearts exposed to acute ischemia,
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testosterone significantly reduced norepinephrine release and
consequent arrhythmias (49).
Arrhythmogenic Cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an
inherited heart disease that is associated with life-threatening
ventricular arrhythmias. It is one of the leading causes of SCD,
especially in the young, athletic population (50). While risk
stratification traditionally relied on measurements of structural
dysfunction and electrophysiological indices (51), there have
been recent attempts to identify circulating biomarkers for
prediction of arrhythmic risk. Among these, sex hormones, and
particularly testosterone, seem to play an important role in
arrhythmogenesis. In the study by Akdis et al. (52) our group
investigated the role of sex hormones and their association
with major arrhythmic cardiac events (MACE) in patients with
ARVC. We observed that elevated serum testosterone levels were
independently associated with MACE in male ARVC patients,
whereas estradiol levels were significantly lower in female
patients with MACE. These findings have recently been validated
in another study by Ren et al. (53) in a different ARVC cohort.
The study showed that testosterone levels were a strong predictor
of future adverse arrhythmic events in male patients with ARVC,
independently from baseline systolic function. However, there
was no association between the circulating levels of sex hormones
and future heart failure events.
It is important to note that SCD may occur during early,
clinically occult stage of ARVC, which still bears the pathological
hallmarks of progressive cardiomyocyte loss and fibrofatty
infiltration. Hence, there is an underlying electrophysiological
substrate in ARVC that can facilitate reentry. This is in contrast
with the mechanisms of arrhythmogenesis in patients with
outflow tract ventricular tachyarrhythmias in the absence of
structural heart disease. The study by Hu et al. (54) did not
reveal any differences in circulating testosterone levels between
diseased and control males with such idiopathic arrhythmias,
while estradiol levels were indeed lower in diseased males. While
the proarrhythmogenic effect of testosterone in ARVC may be
partially related to increased apoptosis and lipogenesis, as shown
in the study by Akdis et al. (52) arrhythmia susceptibility in
patients with idiopathic outflow tract tachyarrhythmias may be
due to estrogen deficiency and its consequences on the cardiac
calcium and potassium channels, as discussed previously.
Takotsubo Syndrome
Takotsubo Syndrome is characterized by acute and mostly
transient left ventricular dysfunction, which is often preceded by
emotional or physical triggers. The patients have a substantial
risk for MACE (55). The fact that this condition typically occurs
in post-menopausal women (up to 90% of cases) has pointed
out the role of estrogen deficiency as a causal factor, although
pathophysiological mechanisms underlying the disease are still
largely debated. The lack of estrogen together with an excess in
catecholamines may not only underlie the pathophysiology of
the disease itself, but also the risk of arrhythmic complications.
This has been shown in a small study by El-Battrawy et al. (56)
on hiPSC-CMs, which demonstrated that catecholamine excess
may increase reactive oxygen species (ROS) production, which
in turn enhances the late sodium current (INa) and suppresses
the Ito, causing prolongation of AP duration. Interestingly,
when these hiPSC-CMs were treated with estradiol, this reduced
their sensitivity to catecholamines by reducing adrenoreceptor
expression, and thus, showed a protective effect of estrogen in the
context of this disease. Further studies are needed to determine
the exact pathophysiologic and prognostic role of sex hormones
in Takotsubo Syndrome.
Cardiac Channelopathies
Long QT Syndrome (LQTS)
This condition defines prolonged rate-corrected QT intervals
(QTc) in patients who are at risk for ventricular tachyarrhythmias
(typically TdP) and SCD (36). LQTS can be either congenital
or acquired (as is the case for drug-induced LQTS). Female
sex is known to be an independent risk factor, as females
have 10–20ms longer QTc intervals. However, the gender
difference only manifests after puberty, suggesting that female
sex hormones may play a role in the increased propensity for
arrhythmias (36, 57, 58).
The QTc is most affected by alterations in phase 2 and 3 of
the AP, which are dominated, respectively, by the L-type calcium
current (upregulation lengthens the QTc) and the delayed
rectifier potassium currents (Ikr and Iks upregulation shortens
the QTc). As mentioned previously, estrogen, progesterone
and testosterone have varying effects on these currents,
which could explain the gender differences (7). While the
hypothesis that increased estrogen might be responsible for
arrhythmogenesis in females has not been proven in humans
yet, there are several clinical studies showing that QTc and
arrhythmogenicity may increase in in males with decreased
testosterone. A recent study by Salem et al. (59) has reported
that male hypogonadism secondary to androgen-deprivation
therapies (ADTs) is associated with acquired LQTS and increased
incidence of TdP. Furthermore, the same group has also studied
hiPSCs from men and treated them either with ADTs and
dihydrotestosterone, reporting that while the ADTs indeed
prolonged the QT interval, this was acutely reversed upon
dihydrotestosterone administration (60).
Brugada Syndrome
This genetically-determined disease is characterized by the
appearance of a coved-type ST segment elevation in the right
precordial ECG leads, and puts the patients at significant risk
for SCD in the absence of an underlying structural heart disease
(61). The most common genetic mutations found in affected
patients (up to 25%) are loss-of-function mutations in the
SCN5A gene, which encodes the α subunit of the cardiac sodium
channel protein (Nav1.5) (62). Despite the autosomal dominant
inheritance of the disease, its incidence is significantly higher
in males (8:1 in Western countries and 9:1 in Asia). Indeed,
a study by Shimizu et al. (42) showed that males with the
Brugada Syndrome had significantly higher testosterone levels
as compared to their control counterparts, even after adjusting
for age, exercise, stress, smoking habits, and medications.
Furthermore, there are a few interesting case reports correlating
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the Brugada ECG pattern to blood testosterone levels. Matsuo
et al. (63) described two cases of males with an asymptomatic
Brugada ECG pattern, which disappeared following surgical
castration for prostate cancer. Another recently published case
study by Sichrovsky et al. (64) has demonstrated the development
of a previously unrecognized Brugada pattern and SCD in a
genetic female living as a transgender male through the use of
exogenous testosterone.
As previous literature has suggested, the accentuation of the
epicardial AP notch and loss of its dome induced by a potassium
channel opener, seems to be the cause of the typical Brugada-
type ST segment elevation. This can result in phase II reentry
and trigger ventricular tachycardia or ventricular fibrillation
(65). Moreover, it matches the evidence of the sodium channel
being the primary gene candidate for the Brugada Syndrome.
Since either a decrease in the density or an acceleration of
inactivation of the sodium channel would leave Ito unopposed
during the early phases of the AP, the mechanism of the AP
notch accentuation may indeed be due to a more prominent Ito,
which is physiologically more expressed in males as compared to
females. This has been proven in a dog model, showing that the
Ito current density of the RV epicardium is significantly higher
in males than in females, culminating in increased transmural
dispersion of repolarization (4). This substrate facilitates the
presence of the Brugada-type ECG pattern and occurrence of
arrhythmias in males. Furthermore, as previously mentioned,
testosterone may augment outward repolarizing currents (such
as Ikr and Iks), and thus, lead to loss of the AP dome, explaining
the male predominance of the Brugada Syndrome. A recently
published in vitro study by Yang et al. (66) examining the
effects of estrogen and testosterone on the wild-type and the
mutant Nav1.5 has shown no influence of these hormones on




CPVT is an inherited arrhythmic syndrome, which affects 1
in 10,000 individuals. It is characterized by potentially lethal
ventricular arrhythmias, which are often biventricular or
polymorphic in origin, and which mostly appear following
an adrenergic challenge precipitated by emotional or physical
stress (67). CPVT arises from disrupted intracellular calcium
homeostasis and is most often associated with gene abnormalities
involving the RyR2. The resulting dysregulated RyR2-mediated
leak of sarcoplasmic reticular calcium elevates cytosolic calcium,
increasing electrogenic sodium/calcium exchanger and/or
calcium-activated chloride transient inward currents. The
consequently occurring delayed afterdepolarizations may trigger
arrhythmic events. Interestingly, the majority of phenotypes
related to RyR2 mutations show a higher mortality in males as
compared to females. The molecular basis for this entity has been
explored in a recent study by Saadeh et al. (68) in a murine model
of CPVT (homozygotic RyR2S/S), in which they investigated
the impact of gender on the expression levels of molecular
determinants of calcium homeostasis and conduction velocity.
While the authors have found no difference in the expression
levels of calcium homeostasis proteins, they showed a decreased
Cx43 expression, which correlated with slowed conduction
velocity in female mice, but not in males.
HORMONE REPLACEMENT THERAPY
AND ARRHYTHMIAS
Male hypogonadism, which may arise from multiple etiologies
including androgen-deprivation therapy (ADT), has been
reported as a risk factor for acquired LQTS and the occurrence
of TdP. This has led to multiple pharmacovigilance studies
assessing the link between hormone replacement therapy (HRT)
and the incidence of ventricular arrhythmias. Interestingly, this
has helped to shed some light on the link between arrhythmias
and sex hormones, supporting the hypothesis that hypogonadism
is a correctable and identifiable risk factor for TdP, especially
in men. This has clinical implications, for example while
considering ADT, which is the cornerstone of the treatment of
prostate cancer.
Ventricular Arrhythmias
Male hypogonadism is a condition in which clinical symptoms
occur due to testosterone deficiency (69). As discussed
previously, low testosterone values may be associated with
a higher risk of ventricular arrhythmias and SCD due to a
lengthening of the myocardial repolarization phase. In fact, the
QTc values of males after puberty are significantly shorter and
aging men with decreasing testosterone levels seem to have a
gradual increase in QTc. Some types of male hypogonadism
can be treated with testosterone replacement therapy (TRT).
The data available on the effects of TRT on cardiovascular
risks are contradicting. The RHYME study, which investigated
hypogonadal men receiving TRT, did not find any increased
cardiovascular risk (70). The same results were shown in a
systematic review by Corona et al. (71) which reported the
absence of a causal role between TRT and cardiovascular events.
Interestingly, a study by Muensterman et al. (58) reported that in
older men, the use of transdermal testosterone combined with
oral progesterone attenuates drug-induced QTc lengthening.
This shows that there may be a probable protective role of both
testosterone and progesterone on arrhythmia occurrence due to
prolonged QTc.
Concerning hormone replacement in females, there are
several studies in post-menopausal women showing that estrogen
replacement therapy (ERT) prolongs the QTc interval. Indeed,
as mentioned above, estrogen has a lengthening effect on the
myocardial repolarization phase. This effect is not evident in
female children, but only manifests itself after adolescence,
and significantly decreases after menopause (72). A study on
hormone replacement for 1 year confirmed that the use of ERT
increases the QTc interval (73). Interestingly, this effect was
not seen in combined estrogen-progestin replacement therapies,
strengthening the theory that progesterone most likely has a
similar effect on the QTc interval as testosterone. It is important
to note that a study by Saba et al. (74) did not find any
significant difference in QTc interval between premenopausal,
post-menopausal and post-menopausal women treated with
hormone replacement. A major limitation of this study was
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that it was not clear whether hormone replacement consisted
of estrogen alone or combined with progesterone in the study
population (74).
CONCLUSIONS
Gender is known to be an independent risk factor for some
types of cardiac arrhythmias. However, the link between
the sex hormones and susceptibility to arrhythmias is still
a matter of debate. Nonetheless, despite conflicting results,
these hormones may influence arrhythmia occurrence both
in the presence or absence of underlying structural heart
disease. Further studies, which validate or contradict the already
present literature, will be of invaluable importance to fully
understand the pathophysiological mechanisms that lie at the
basis of arrhythmogenesis.
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